Medical tech firm TransMedics Group, Inc. (Nasdaq: TMDX) has acquired assets and intellectual property from Bridge to Life Ltd. related to Ex-Vivo Organ Support System (EVOSS) and LifeCradle Heart Preservation Transport System technologies. EVOSS is warm perfusion for lung and heart transplantation, and LifeCradle is cold perfusion for heart transplantation. TransMedics plans to integrate these into its OCS platform, aiming to expand product offerings and indications for organ transplants, strengthening its global leadership in the field. Advisors included Canaccord Genuity LLC, Piper Sandler & Co., Ropes & Gray LLP, and Cooley LLP.
TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that is has acquired from Bridge to Life Ltd. (“Bridge to Life”), assets and intellectual property related to the Ex-Vivo Organ Support System (“EVOSS”) and LifeCradle Heart Preservation Transport System (“LifeCradle”) technologies. EVOSS is a warm perfusion technology designed for lung and heart transplantation and LifeCradle is a cold perfusion technology designed for heart transplantation. TransMedics intends to further develop these technologies as the company seeks to expand its product offerings and indications for organ transplantation.
“We are excited for the opportunity to further develop these innovative technologies and incorporate them into our Next-Generation OCS technology platform,” said Waleed Hassanein, MD, President and Chief Executive Officer. “This acquisition positions us to capitalize on significant strategic opportunities to expand our product offering, add new clinical indications, further enhance the National OCS Program (NOP) offering, and maintain our global leadership position in the organ transplant field.”
Canaccord Genuity LLC acted as financial advisor to TransMedics. Piper Sandler & Co. acted as financial advisor to Bridge to Life. Ropes & Gray LLP acted as legal advisor to TransMedics. Cooley LLP acted as legal advisor to Bridge to Life.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: BioSpace